logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 20 of 23 Items
Showing 1 - 20 of 23 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

Nathan N, Borel T, Djibo A, Evans D, Djibo S,  et al.
2008-04-14 • Lancet
2008-04-14 • Lancet
BACKGROUND: In sub-Saharan Africa in the 1990s, more than 600,000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course...
Journal Article
|
Research

Tuberculosis treatment in a refugee and migrant population: 20 years of experience on the Thai-Burmese border

Minetti A, Camelique O, Hsa Thaw K, Thi SS, Swaddiwudhipong W,  et al.
2010-12-01 • International Journal of Tuberculosis and Lung Disease
2010-12-01 • International Journal of Tuberculosis and Lung Disease
SETTING
Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, incl...
Journal Article
|
Research

Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?

Rolland E, Checchi F, Pinoges LLP, Balkan S, Guthmann JP,  et al.
2006-04-01 • Tropical Medicine and International Health
2006-04-01 • Tropical Medicine and International Health
OBJECTIVE: To compare the cost-effectiveness of malaria treatment based on presumptive diagnosis with that of malaria treatment based on rapid diagnostic tests (RDTs). METHODS: We calcul...
Journal Article
|
Research

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.<...
Journal Article
|
Research

Timeliness of Clinic Attendance is a good predictor of Virological Response and Resistance to Antiretroviral drugs in HIV-infected patients

Bastard M, Pinoges LLP, Balkan S, Szumilin E, Ferreyra C,  et al.
2012-11-07 • PLOS One
2012-11-07 • PLOS One
Ensuring long-term adherence to therapy is essential for the success of HIV treatment. As access to viral load monitoring and genotyping is poor in resource-limited settings, a simple to...
Journal Article
|
Research

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Prospective efficacy monitoring of anti-malarial treatments is imperative for timely detection of resistance development. The in vivo efficacy of artesunate-amodiaquine (A...
Journal Article
|
Research

Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin

Dubray C, Ibrahim SA, Abdelmutalib M, Guerin PJ, Dantoine F,  et al.
2008-03-01 • Annals of Tropical Paediatrics
2008-03-01 • Annals of Tropical Paediatrics
BACKGROUND: Systemic antibiotics are routinely prescribed for severe acute malnutrition (SAM). However, there is no consensus regarding the most suitable regimen. In a therapeutic feedin...
Journal Article
|
Research

Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment

Olliaro PL, Pinoges LLP, Checchi F, Vaillant M, Guthmann JP
2008-01-01 • Tropical Medicine and International Health
2008-01-01 • Tropical Medicine and International Health
OBJECTIVE: Parasites may recur asymptomatically after initial clearance by antimalarial treatment. Current guidelines recommend treatment only when patients develop symptoms or at the en...
Journal Article
|
Research

Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy

Pujades-Rodriguez M, Dantony E, Pinoges LLP, Ecochard R, Etard JF,  et al.
2011-11-21 • PLOS One
2011-11-21 • PLOS One
BACKGROUND
To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV ...
Journal Article
|
Research

Immunogenicity of fractional doses of tetravalent A/C/Y/W135 meningococcal polysaccharide vaccine: Results from a randomized non-inferiority controlled trial in Uganda

Guerin PJ, Naess LM, Fogg C, Rosenqvist E, Pinoges LLP,  et al.
2008-12-02 • PLOS Neglected Tropical Diseases
2008-12-02 • PLOS Neglected Tropical Diseases
BACKGROUND: Neisseria meningitidis serogroup A is the main causative pathogen of meningitis epidemics in sub-Saharan Africa. In recent years, serogroup W135 has also been the cause of ep...
Journal Article
|
Research

Methodological issues in the assessment of antimalarial drug treatment: Analysis of 13 studies in eight African countries from 2001 to 2004

Guthmann JP, Pinoges LLP, Checchi F, Cousens S, Balkan S,  et al.
2006-11-01 • Antimicrobial Agents and Chemotherapy
2006-11-01 • Antimicrobial Agents and Chemotherapy
The objectives of these analyses were to assess the feasibility of the latest WHO recommendations (28-day follow-up with PCR genotyping) for the assessment of antimalarial drug efficacy ...
Journal Article
|
Research

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

Calmy A, Pinoges LLP, Szumilin E, Zachariah R, Ford NP,  et al.
2006-05-12 • AIDS
2006-05-12 • AIDS
BACKGROUND
The use fixed-dose combination (FDC) is a critical tool in improving HAART. Studies on the effectiveness of combined lamivudine, stavudine and nevirapine (3TC/d4T/NVP) are...
Journal Article
|
Research

Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children

Ashley EA, Pinoges LLP, Turyakira E, Dorsey G, Checchi F,  et al.
2008-08-09 • Malaria Journal
2008-08-09 • Malaria Journal
BACKGROUND: Use of different methods for assessing the efficacy of artemisinin-based combination antimalarial treatments (ACTs) will result in different estimates being reported, with im...
Journal Article
|
Research

Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial

Priotto G, Kabakyenga JK, Pinoges LLP, Ruiz A, Eriksson T,  et al.
2008-01-25 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2008-01-25 • Transactions of the Royal Society of Tropical Medicine and Hygiene
Drug-resistant malaria is spreading in Africa. The few available drugs might be safeguarded if combined with an artemisinin derivative. We investigated the efficacy, safety, and tolerabi...
Journal Article
|
Research

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

Priotto G, Pinoges LLP, Fursa IB, Burke B, Nicolay N,  et al.
2008-03-05 • British Medical Journal (BMJ)
2008-03-05 • British Medical Journal (BMJ)
Objective: To assess the safety and effectiveness of eflornithine as first line treatment for human African trypanosomiasis. Design: Cohort study. Setting: Control programme in Ibba, sou...
Journal Article
|
Research

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria

Lee SJ, Stepniewska K, Anstey NM, Ashley EA, Barnes KI,  et al.
2008-08-01 • Malaria Journal
2008-08-01 • Malaria Journal
BACKGROUND: Malaria is a very important cause of anaemia in tropical countries. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. For compari...
Journal Article
|
Research

Tuberculosis After HAART Initiation in HIV-Positive Patients from Five Countries with a High Tuberculosis Burden

Bonnet MMB, Pinoges LLP, Varaine FFV, Oberhauser BBO, O'Brien DP,  et al.
2006-06-12 • AIDS
2006-06-12 • AIDS
BACKGROUND: HAART reduces tuberculosis (TB) incidence in people living with HIV/AIDS but those starting HAART may develop active TB or subclinical TB may become apparent in the immune re...
Journal Article
|
Research

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia

Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N,  et al.
2007-01-30 • AIDS
2007-01-30 • AIDS
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...
Journal Article
|
Research

Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda

Ahoua L, Ayikoru H, Gnauck K, Odaru G, Odar E,  et al.
2010-02-01 • Journal of Tropical Pediatrics
2010-02-01 • Journal of Tropical Pediatrics
Prevention of mother-to-child transmission (PMTCT) is essential in HIV/AIDS control. We analysed 2000-05 data from mother-infant pairs in our PMTCT programme in rural Uganda, examining p...
Journal Article
|
Research

Positive Outcomes of HAART at 24 Months in HIV-Infected Patients in Cambodia

Ferradini LLF, Laureillard D, Prak N, Ngeth C, Fernandez MAL,  et al.
2007-11-12 • AIDS
2007-11-12 • AIDS
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunologica...